Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone

British Journal of Pharmacology ◽

10.1038/sj.bjp.0704529 ◽

2002 ◽

Vol 135 (4) ◽

pp. 1060-1068 ◽

Author(s):

Graeme A Deuchar ◽

Andrew Docherty ◽

Margaret R MacLean ◽

Martin N Hicks

Keyword(s):

Nitric Oxide ◽

Pulmonary Hypertension ◽

Left Ventricular Dysfunction ◽

Vascular Tone ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Download Full-text

The role of 5-hydroxytryptamine in the control of pulmonary vascular tone in a rabbit model of pulmonary hypertension secondary to left ventricular dysfunction

Pulmonary Pharmacology & Therapeutics ◽

10.1016/j.pupt.2004.07.006 ◽

2005 ◽

Vol 18 (1) ◽

pp. 23-31 ◽

Author(s):

Graeme A. Deuchar ◽

Martin N. Hicks ◽

Margaret R. MacLean

Keyword(s):

Pulmonary Hypertension ◽

Left Ventricular Dysfunction ◽

Vascular Tone ◽

Ventricular Dysfunction ◽

Rabbit Model ◽

Left Ventricular

Download Full-text

Role of basal release of nitric oxide in the presenceof acute left ventricular dysfunction: Comparative study with normal condition

Journal of Cardiac Failure ◽

10.1016/s1071-9164(96)80007-8 ◽

1996 ◽

Vol 2 (1) ◽

pp. 33-39

Author(s):

Kazuhiro Yamamoto ◽

Tohru Masuyama ◽

Toshiaki Mano ◽

Johji Naito ◽

Hiroya Kondo ◽

...

Keyword(s):

Nitric Oxide ◽

Comparative Study ◽

Left Ventricular Dysfunction ◽

Normal Condition ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Download Full-text

590 Right ventricular dysfunction and pulmonary hypertension are independent prognostic predictors of survival in left ventricular dysfunction regardless of ischemic etiology

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(06)80387-5 ◽

2006 ◽

Vol 5 (1) ◽

pp. 135-135

Author(s):

L LAVECCHIA ◽

L VAROTTO ◽

G SPADARO ◽

C BONANNO ◽

P VINCENZI ◽

...

Keyword(s):

Pulmonary Hypertension ◽

Right Ventricular ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Right Ventricular Dysfunction ◽

Left Ventricular ◽

Prognostic Predictors

Download Full-text

Faculty Opinions recommendation of Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020475.793481557 ◽

2013 ◽

Author(s):

Arvind Bhimaraj

Keyword(s):

Pulmonary Hypertension ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Dose Ranging ◽

Hemodynamic Study

Download Full-text

Nitric Oxide Inhibits the Positive Inotropic Response to β-Adrenergic Stimulation in Humans With Left Ventricular Dysfunction

Circulation ◽

10.1161/01.cir.92.8.2198 ◽

1995 ◽

Vol 92 (8) ◽

pp. 2198-2203 ◽

Author(s):

Joshua M. Hare ◽

Evan Loh ◽

Mark A. Creager ◽

Wilson S. Colucci

Keyword(s):

Nitric Oxide ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Inotropic Response ◽

Adrenergic Stimulation

Download Full-text

Role of microvascular dysfunction in left ventricular dysfunction in type 2 diabetes mellitus

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2021.107907 ◽

2021 ◽

Vol 35 (5) ◽

pp. 107907

Author(s):

Amera Halabi ◽

Mark Nolan ◽

Elizabeth Potter ◽

Leah Wright ◽

Atef Asham ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Microvascular Dysfunction ◽

Left Ventricular

Download Full-text

742 Systolic septal flattening as a sign of pulmonary hypertension varies with left ventricular dysfunction: A study in ventricular interaction

European Journal of Echocardiography ◽

10.1016/s1525-2167(06)60465-4 ◽

2006 ◽

Vol 7 ◽

pp. S124-S124

Author(s):

M VATURI ◽

M HANDSCHUMACHER ◽

A SAGIE ◽

R LEVINE

Keyword(s):

Pulmonary Hypertension ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Ventricular Interaction

Download Full-text

Endothelial Nitric Oxide Synthase-Induced Hypertrophy and Vascular Dysfunction Contribute to the Left Ventricular Dysfunction in Caveolin-1−/− Mice

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2017.09.015 ◽

2017 ◽

Vol 33 (12) ◽

pp. 1716-1724 ◽

Author(s):

Annette Ebner ◽

Nadine Kuerbis ◽

Aljoscha Brandt ◽

Birgit Zatschler ◽

Sönke Weinert ◽

...

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Left Ventricular Dysfunction ◽

Endothelial Nitric Oxide Synthase ◽

Ventricular Dysfunction ◽

Vascular Dysfunction ◽

Left Ventricular ◽

Oxide Synthase ◽

Endothelial Nitric Oxide

Download Full-text

Antiarrhythmic Drug Therapy for Patients with Ventricular Tachyarrhythmias in the Setting of Left Ventricular Dysfunction: 1. The Role of Propafenone 2. The Role of Adjunct Beta-Blockade

Developments in Cardiovascular Medicine - Pharmacological Aspects of Heart Disease ◽

10.1007/978-1-4613-2057-9_4 ◽

1987 ◽

pp. 45-57

Author(s):

M. A. Brodsky ◽

B. J. Allen ◽

C. Luckett ◽

R. Thomas

Keyword(s):

Drug Therapy ◽

Antiarrhythmic Drug ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Beta Blockade ◽

Ventricular Tachyarrhythmias ◽

Antiarrhythmic Drug Therapy

Download Full-text

Emerging Role of Genetic Variants of Matrix Metalloproteinases Genes in Left Ventricular Dysfunction

Role of Proteases in Cellular Dysfunction ◽

10.1007/978-1-4614-9099-9_17 ◽

2013 ◽

pp. 321-334

Author(s):

Balraj Mittal ◽

Avshesh Mishra ◽

Anshika Srivastava ◽

Naveen Garg

Keyword(s):

Matrix Metalloproteinases ◽

Left Ventricular Dysfunction ◽

Genetic Variants ◽

Ventricular Dysfunction ◽

Left Ventricular

Download Full-text